Anthony R. Hunter
| Anthony Rex Hunter | |
|---|---|
| Born | 23 August 1943 United Kingdom |
| Nationality | British |
| Fields | Biology |
| Institutions | Salk Institute University of California, San Diego |
| Alma mater | Felsted, University of Cambridge |
| Known for | kinase |
| Notable awards | Wolf Prize in Medicine (2005) |
Anthony Rex Hunter (born 23 August 1943) is a British-American biologist who is a Professor of Biology at the Salk Institute for Biological Studies and the University of California, San Diego. His research publications list his name as Tony Hunter.[1]
Contents |
[edit] Early life
Anthony R. Hunter was born in 1943 in the United Kingdom and educated at Felsted, prior to Christ's College at Cambridge University.
[edit] Career
He received a Ph.D. from the University of Cambridge, in Cambridge, England and held a fellowship at Christ's College in Cambridge (1968–1971) and (1973–1975). From 1971 to 1973, he was a research associate of the Salk Institute for Biological Studies in La Jolla, California. He was then assistant professor 1975-78, associate professor 1978-82, professor 1982 onwards and since 2008 director of the Salk Institute Cancer Center.[2]
[edit] Research
Dr. Hunter is one of the foremost recognized leaders in the field of cell growth control, growth factor receptors and their signal transduction pathways.
He is well-known for discovering that tyrosine phosphorylation is a fundamental mechanism for transmembrane-signal transduction in response to growth factor stimulation and that disregulation of such tyrosine phosphorylation, by activated oncogenic protein tyrosine kinases,[3] is a pivotal mechanism utilized in the malignant transformation of cells. His work is important in signaling pathways and their disorders.
He was a founder of Signal Pharmaceuticals.
He won the Wolf Prize in Medicine in 2005 for "the discovery of protein kinases that phosphorylate tyrosine residues in proteins, critical for the regulation of a wide variety of cellular events, including malignant transformation".[4]
[edit] Awards and honors
- 1987 Fellow of the Royal Society[5]
- 1994 Charles S. Mott Prize by the General Motors Cancer Research Foundation.
- 2001 Keio Medical Science Prize[6]
- 2004 Louisa Gross Horwitz Prize from Columbia University.[7]
- 2006 Pasarow Award in Cancer Research.[8]
- Member of the US National Academy of Science.[9]
[edit] References
- ^ Minichromosome maintenance proteins interact with ...[Mol Cell Biol. 2008] - PubMed Result
- ^ "Tony Hunter FRS". Debretts. http://www.debretts.com/people/biographies/browse/h/7068/Anthony%20Rex%20%28Tony%29+HUNTER.aspx. Retrieved 18 July 2010.
- ^ Hunter, Tony (May 2008). "Tony Hunter: kinase king. Interview by Ruth Williams". J. Cell Biol. 181 (4): 572–3. doi:10.1083/jcb.1814pi. PMC 2386096. PMID 18490508. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2386096.
- ^ The Wolf Prize in Medicine
- ^ "Lists of Royal Society Fellows 1660-2007". London: The Royal Society. http://royalsociety.org/Lists-of-Royal-Society-Fellows-1660-2007/. Retrieved 18 July 2010.[dead link]
- ^ The Keio Medical Science Prize
- ^ Tony Hunter at The Salk Institute
- ^ InsideSalk - 11|07 Issue - Tony Hunter Receives Pasarow Award for Cancer Research
- ^ PNAS Member Editor Details
[edit] External links
- The Wolf Prize in Medicine in 2005 (detail)
- The Official Site of Louisa Gross Horwitz Prize
- Hunter, Tony at ISIHighlyCited.com
|
||||||||
